Screener
iRhythm Holdings, Inc. IRTC Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$224.2MBeat by $4.9M
EPS-$0.01Beat by $0.03
Revenue estimate$219.3M
EPS estimate-$0.04
“Our second quarter results reflect strong execution across the business, with broad-based growth, meaningful margin expansion, and continued progress against our strategic priorities. We are driving adoption across an increasingly diverse set of care settings and channels, including primary care, while continuing to invest in the capabilities that we believe will shape the future of healthcare. We are also thrilled to have entered into a definitive agreement to acquire VitalConnect, a transaction we believe will allow us to serve more patients, while also creating long-term value for clinicians and stockholders.”
Next report
Oct 29, 2026 (in a month)Revenue estimate$222.4M
EPS estimate$0.02
Valuation & ratios
Segments
By product
Versus estimates
Revenue
Diluted EPS
FAQ
- When did iRhythm Holdings, Inc. report Q2 2026 earnings?
- iRhythm Holdings, Inc. (IRTC) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were iRhythm Holdings, Inc.'s Q2 2026 revenue and EPS?
- iRhythm Holdings, Inc. reported revenue of $224.2M and eps of $-0.01 for Q2 2026.
- Did iRhythm Holdings, Inc. beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $219.3M by $4.9M. EPS beat the consensus estimate of $-0.04 by $0.03.
- How did iRhythm Holdings, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 20.1% from $186.7M a year earlier and eps grew 96.9% from $-0.32.
- Where can I find iRhythm Holdings, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001388658-26-000070) and the 10-Q periodic report (0001388658-26-000072) directly on SEC EDGAR. The filing index links above go to sec.gov.
